As the US works to contain the spread of the novel coronavirus, testing has become a crucial part of identifying, tracking, and isolating new infections.
The USDA and FDA recently announced an emergency use authorization for
The ruling only applies to one specific kind of test from a single company, LabCorp. The company already had approval for
Currently, the kits are available online for $119, which includes two-way overnight shipping. To order one, however, you need to complete an eligibility questionnaire online.
Tests are available only to certain medical workers
Since the supply of testing kits is limited, first responders and medical workers have priority in ordering them, according to the LabCorp website. According to a representative, the company plans to make tests more broadly available in the near future, although a specific timeline hasn't been released.
"We expect to expand the availability of the self-collection kits to additional patients assuming adequate supplies. However, it is premature to comment further about exact timing," a spokesperson for LabCorp told Business Insider via email.
The tests also aren't available in New York, New Jersey, Maryland, and Rhode Island, since those four states have additional regulations on testing procedures.
"Emergency use" means that the test has data to support its use, but has not been formally approved by the FDA and can only be used as long as the emergency circumstances continue.
Any other companies looking to offer at-home testing kits would require an additional emergency use authorization, according to the FDA. The FDA had previously cracked down on startup companies attempting to create at-home testing kits without approval.
Home tests could be more accessible and less invasive that other diagnostics, but still aren't perfect
So far, the FDA hasn't authorized any coronavirus that are fully processed at home.
The home kits allow you to collect a nasal sample at home using a swab inserted inside the nostril. The samples then must be mailed to a lab for testing. But this procedure is far less invasive than other tests that require medical workers to insert a swab deep into the patient's nose and throat.
Self-swabbing can be just as effective as swabs administered by healthcare professional, according to recent research from UnitedHealth Group. It may also be safer, since self-swabbing protects medical staff from being in close proximity to patients and potentially infectious particles.
Prior to authorizing the LabCorp test, the FDA previously allowed self-swabbing only in clinical settings, such as a drive-through test clinic, TechCrunch reported.
Read the original article on Business Insider